- Record: found
- Abstract: not found
- Article: not found
Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF
Karola S. Jering ,
Faiez Zannad ,
Brian Claggett ,
Finnian R. Mc Causland ,
João Pedro Ferreira ,
Akshay Desai ,
Ebrahim Barkoudah ,
John J.V. McMurray ,
Marc A. Pfeffer ,
Scott D. Solomon
January 2021
January 2021
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
<p class="first" id="d259205e150">This study sought to evaluate the efficacy and safety
of sacubitril/valsartan in patients
with heart failure with preserved ejection fraction (HFpEF) according to background
mineralocorticoid receptor antagonist (MRA) therapy.
</p>